Ziprasidone
Back to searchMolecule Structure
Scientific Name
Ziprasidone
Description of the Drug
Ziprasidone is an atypical antipsychotic used to manage schizophrenia, bipolar mania, and agitation in patients with schizophrenia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00246
http://www.drugbank.ca/drugs/DB00246
Brand Name(s)
Not Available
Company Owner(s)
Apotex Inc, Cadila Healthcare Ltd, Viatris Specialty Llc, Lupin Pharmaceuticals Inc, Sandoz Inc, Macleods Pharmaceuticals Ltd, Chartwell Rx Sciences Llc, Gland Pharma Ltd, Aurobindo Pharma Ltd, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Dopamine D2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL217 |
Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
Serotonin 2c (5-HT2c) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL225 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL28028 | |||
PharmGKB | PA451974 | |||
Human Metabolome Database | HMDB0014391 | |||
DrugBank | DB00246 | |||
PubChem: Thomson Pharma | 14782044 | |||
PubChem | 60854 | |||
LINCS | LSM-5433 | |||
Nikkaji | J553.147K | |||
BindingDB | 50048803 | |||
EPA CompTox Dashboard | DTXSID4023753 | |||
DrugCentral | 2865 | |||
Brenda | 80130 | |||
ChemicalBook | CB62131294 | |||
Guide to Pharmacology | 59 | |||
rxnorm | ZIPRASIDONE | ZIPRASIDONE HYDROCHLORIDE | ZIPRASIDONE MESYLATE | GEODON |
KEGG Ligand | C07568 | |||
ChEBI | 10119 | |||
ZINC | ZINC000000538550 |